These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 32464049)

  • 1. Defining the Neural Kinome: Strategies and Opportunities for Small Molecule Drug Discovery to Target Neurodegenerative Diseases.
    Krahn AI; Wells C; Drewry DH; Beitel LK; Durcan TM; Axtman AD
    ACS Chem Neurosci; 2020 Jul; 11(13):1871-1886. PubMed ID: 32464049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein kinases CK1 and CK2 as new targets for neurodegenerative diseases.
    Perez DI; Gil C; Martinez A
    Med Res Rev; 2011 Nov; 31(6):924-54. PubMed ID: 20577972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in Applying Computer-Aided Drug Design for Neurodegenerative Diseases.
    Salman MM; Al-Obaidi Z; Kitchen P; Loreto A; Bill RM; Wade-Martins R
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene discovery and validation for neurodegenerative diseases.
    Mathisen PM
    Drug Discov Today; 2003 Jan; 8(1):39-46. PubMed ID: 12546990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabinoid pharmacology/therapeutics in chronic degenerative disorders affecting the central nervous system.
    Aymerich MS; Aso E; Abellanas MA; Tolon RM; Ramos JA; Ferrer I; Romero J; Fernández-Ruiz J
    Biochem Pharmacol; 2018 Nov; 157():67-84. PubMed ID: 30121249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current Small Molecule-Based Medicinal Chemistry Approaches for Neurodegeneration Therapeutics.
    Sanghai N; Vuong B; Burak Berk A; Afridi MSK; Tranmer GK
    ChemMedChem; 2024 May; 19(9):e202300705. PubMed ID: 38329887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterizing the role of the dark kinome in neurodegenerative disease - A mini review.
    Axtman AD
    Biochim Biophys Acta Gen Subj; 2021 Dec; 1865(12):130014. PubMed ID: 34547390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dementia of Alzheimer's disease and other neurodegenerative disorders--memantine, a new hope.
    Sonkusare SK; Kaul CL; Ramarao P
    Pharmacol Res; 2005 Jan; 51(1):1-17. PubMed ID: 15519530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New opportunities for treatment and prevention of neurodegenerative diseases with PTP1B inhibitors.
    Kołodziej D; Sobczak Ł; Łączkowski KZ
    Future Med Chem; 2023 Aug; 15(16):1443-1447. PubMed ID: 37610866
    [No Abstract]   [Full Text] [Related]  

  • 10. Emerging roles of protein kinases in microglia-mediated neuroinflammation.
    Lee SH; Suk K
    Biochem Pharmacol; 2017 Dec; 146():1-9. PubMed ID: 28684305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain penetrant kinase inhibitors: Learning from kinase neuroscience discovery.
    Shi Y; Mader M
    Bioorg Med Chem Lett; 2018 Jun; 28(11):1981-1991. PubMed ID: 29752185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurodegenerative diseases linked to misfolded proteins and their therapeutic approaches: A review.
    Khanam H; Ali A; Asif M; Shamsuzzaman
    Eur J Med Chem; 2016 Nov; 124():1121-1141. PubMed ID: 27597727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. iPSC-based disease modeling and drug discovery in cardinal neurodegenerative disorders.
    Okano H; Morimoto S
    Cell Stem Cell; 2022 Feb; 29(2):189-208. PubMed ID: 35120619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinase inhibitors as potential therapeutics for acute and chronic neurodegenerative conditions.
    Cuny GD
    Curr Pharm Des; 2009; 15(34):3919-39. PubMed ID: 19751204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sirtuins and Their Implications in Neurodegenerative Diseases from a Drug Discovery Perspective.
    Yeong KY; Berdigaliyev N; Chang Y
    ACS Chem Neurosci; 2020 Dec; 11(24):4073-4091. PubMed ID: 33280374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of Multifunctional Molecules as Potential Therapeutic Candidates for Alzheimer's Disease, Parkinson's Disease, and Amyotrophic Lateral Sclerosis in the Last Decade.
    Savelieff MG; Nam G; Kang J; Lee HJ; Lee M; Lim MH
    Chem Rev; 2019 Jan; 119(2):1221-1322. PubMed ID: 30095897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The contribution of the peripheral immune system to neurodegeneration.
    Berriat F; Lobsiger CS; Boillée S
    Nat Neurosci; 2023 Jun; 26(6):942-954. PubMed ID: 37231108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Alcohol Drinking in Alzheimer's Disease, Parkinson's Disease, and Amyotrophic Lateral Sclerosis.
    Peng B; Yang Q; B Joshi R; Liu Y; Akbar M; Song BJ; Zhou S; Wang X
    Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32230811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarkers in Neurodegenerative Diseases.
    Jeromin A; Bowser R
    Adv Neurobiol; 2017; 15():491-528. PubMed ID: 28674995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Challenges and opportunities in CNS delivery of therapeutics for neurodegenerative diseases.
    Barchet TM; Amiji MM
    Expert Opin Drug Deliv; 2009 Mar; 6(3):211-25. PubMed ID: 19290842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.